Firefly protein lights pathway to improved detection of blood clots

Dec 08, 2010

The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or treat blood clots, scientists are reporting. Their study appears in the ACS' monthly journal Bioconjugate Chemistry.

Bruce Branchini and colleagues describe a need for new medical imaging agents that emit near-infrared light — the light rays that "night vision" technology detects, enabling soldiers to see in the dark. Those rays penetrate deeper into the body and could give doctors a better way of detecting the proteins involved in blood clotting. Scientists already use luciferase, the enzyme that makes lightning bugs glow, in laboratory research.

The new study describes an advance toward using luciferase in medical imaging. The scientists combined a protein obtained from firefly luciferase with a special dye that allows the protein to emit near-infrared light. In laboratory experiments, the new material successfully detected minute amounts of a specific blood protein, called factor Xa, which is used to monitor the effectiveness of treatment. It offers promise for improved monitoring of heparin therapy, the article suggests.

Explore further: A new synthetic amino acid for an emerging class of drugs

More information: "Chemically Modified Firefly Luciferase Is an Efficient Source of Near-Infrared Light", Bioconjugate Chemistry.

add to favorites email to friend print save as pdf

Related Stories

Simple new method detects contaminants in life-saving drug

Nov 17, 2008

(PhysOrg.com) -- The blood-thinning drug heparin is highly effective when used to prevent and treat blood clots in veins, arteries and lungs, but earlier this year its reputation as a lifesaver was sullied when contaminated ...

New fluorescent label sheds light on brain diseases

Nov 05, 2007

In an advance that may speed progress toward new diagnostic tests for Alzheimer’s disease (AD) and Parkinson’s disease (AD), scientists in New York are reporting development of the first direct method for measuring a ...

Recommended for you

Scientists make diseased cells synthesize their own drug

1 hour ago

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing ...

A new synthetic amino acid for an emerging class of drugs

Aug 31, 2014

Swiss scientists have developed a new amino acid that can be used to modify the 3-D structure of therapeutic peptides. Insertion of the amino acid into bioactive peptides enhanced their binding affinity up to 40-fold. Peptides ...

User comments : 0